Antony Koblish - 31 Mar 2022 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Executive Officer, Director
Signature
/s/ Megan Smeykal, Attorney-in-fact
Issuer symbol
TELA
Transactions as of
31 Mar 2022
Net transactions value
-$4,466
Form type
4
Filing time
01 Apr 2022, 16:43:01 UTC
Previous filing
25 Feb 2022
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Tax liability $4,466 -384 -0.16% $11.63 237,853 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.